Kaufman Elizabeth S, Bloomfield Daniel M, Steinman Richard C, Namerow Pearila B, Costantini Ottorino, Cohen Richard J, Bigger J Thomas
Heart and Vascular Research Center, MetroHealth Campus of Case Western Reserve University, Cleveland, Ohio 44109-1998, USA.
J Am Coll Cardiol. 2006 Oct 3;48(7):1399-404. doi: 10.1016/j.jacc.2006.06.044. Epub 2006 Sep 12.
This study tested the hypothesis that an "indeterminate" microvolt T-wave alternans (MTWA) test, when due to ectopy, unsustained MTWA, or low exercise heart rate (HR), has prognostic significance similar to a positive MTWA test.
MTWA testing, used to stratify risk of sudden or total mortality in patients with structural heart disease, has been limited by a substantial number of "indeterminate" tests. Indeterminate tests are due to patient factors--excessive ventricular ectopy during exercise, unsustained MTWA, or failure to achieve a HR of 105 beats/min for 1 min--or technical factors such as a noisy recording or an exercise protocol that causes an excessively rapid rise in HR.
Patients in sinus rhythm with left ventricular ejection fraction < or =0.40 underwent MTWA exercise tests, analyzed with the spectral method and classified by a computerized interpretation algorithm. The primary end point was all-cause mortality or documented non-fatal sustained ventricular arrhythmia (SVA). "Indeterminate" tests were reviewed jointly by 2 readers blinded to subsequent events to determine the primary reason for indeterminacy.
Participants (N = 549) were 56 +/- 13 years and 71% male; 49% had ischemic cardiomyopathy. There were 40 deaths and 11 non-fatal SVA. Most (94%) indeterminate results were due to patient factors. The 2-year rate for death or SVA was 17.8% in patients with an "indeterminate" MTWA test compared with 12.3% in those with a positive test.
In patients with left ventricular dysfunction, an "indeterminate" MTWA test due to patient factors predicted death or SVA at least as well as a positive test.
本研究检验了这样一个假设,即因异位搏动、非持续性微伏级T波电交替(MTWA)或运动心率(HR)较低导致的“不确定”MTWA检测结果与阳性MTWA检测结果具有相似的预后意义。
MTWA检测用于对结构性心脏病患者的猝死或全因死亡风险进行分层,但受到大量“不确定”检测结果的限制。不确定检测结果是由患者因素导致的,如运动期间室性早搏过多、非持续性MTWA或未能在1分钟内达到105次/分钟的心率,或由技术因素导致的,如记录嘈杂或运动方案导致心率过快上升。
对左心室射血分数≤0.40的窦性心律患者进行MTWA运动试验,采用频谱法分析,并通过计算机解释算法进行分类。主要终点是全因死亡或记录在案的非致死性持续性室性心律失常(SVA)。由两名对后续事件不知情的读者共同审查“不确定”检测结果,以确定不确定的主要原因。
参与者(N = 549)年龄为56±13岁,男性占71%;49%患有缺血性心肌病。有40例死亡和11例非致死性SVA。大多数(94%)不确定结果是由患者因素导致的。“不确定”MTWA检测结果的患者2年死亡或SVA发生率为17.8%,而阳性检测结果的患者为12.3%。
在左心室功能不全的患者中,因患者因素导致的“不确定”MTWA检测结果对死亡或SVA的预测能力至少与阳性检测结果相当。